In addition, following treatment with iTAK1, the cell surface (Fig. 7B) and mRNA levels of cardiac hypertrophy markers (Fig. 7C) were very similar, despite GCN5 overexpression and PE stimulation. The gene discussed is KAT2B; the disease is cardiac hypertrophy.